Aastrom secures US patent for autologous cell therapy product Aastrom Biosciences.

Drug and Food Administration. The business also submitted papers to the FDA in support of special protocol assessments for this program. Aastrom now has 26 U.S. And 36 international patents covering the composition, production and use of mixed-cell products.. Aastrom secures US patent for autologous cell therapy product Aastrom Biosciences, Inc., a respected developer of expanded autologous cellular treatments for severe, chronic cardiovascular diseases, today announced that it’s been granted a U.S.The technique provides: the metrical extension in two-measurements of the residual hepatocellular set including the region of vacuoles pertinent to unusual lipid accumulation; the geometric way of measuring the swelling basin, distinguishing intra-basin space and extra-basin dispersed parenchymal leukocytes; he magnitude of collagen islets, which were regarded as truncated fractals and classified into three classes of magnitude; and the Tectonic Index that quantifies alterations in the business of liver cells.